These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 10491417)
1. A novel role for the cyclin-dependent kinase inhibitor p27(Kip1) in angiotensin II-stimulated vascular smooth muscle cell hypertrophy. Braun-Dullaeus RC; Mann MJ; Ziegler A; von der Leyen HE; Dzau VJ J Clin Invest; 1999 Sep; 104(6):815-23. PubMed ID: 10491417 [TBL] [Abstract][Full Text] [Related]
2. [The role of cyclin-dependent kinase inhibitors in hyperplasia and hypertrophy of vascular smooth muscle cells]. Xu D; Wang M; Liu Y Zhonghua Yi Xue Za Zhi; 2001 Jun; 81(11):680-3. PubMed ID: 11798949 [TBL] [Abstract][Full Text] [Related]
3. Differential regulation of p27(Kip1) expression by mitogenic and hypertrophic factors: Involvement of transcriptional and posttranscriptional mechanisms. Servant MJ; Coulombe P; Turgeon B; Meloche S J Cell Biol; 2000 Feb; 148(3):543-56. PubMed ID: 10662779 [TBL] [Abstract][Full Text] [Related]
4. Angiotensin II regulates the cell cycle of vascular smooth muscle cells from SHR. Kubo A; Fukuda N; Teng J; Satoh C; Nakayama M; Kishioka H; Kanmatsuse K Am J Hypertens; 2000 Oct; 13(10):1117-24. PubMed ID: 11041167 [TBL] [Abstract][Full Text] [Related]
5. [The role of AT1 receptor and cyclin kinase inhibitor p27 protein in angiotensin II-induced hypertrophy of mesangial cell]. Mei X; Gao C; Cui R Zhonghua Nei Ke Za Zhi; 2001 Sep; 40(9):609-12. PubMed ID: 11758242 [TBL] [Abstract][Full Text] [Related]
6. Identification of a novel redox-sensitive gene, Id3, which mediates angiotensin II-induced cell growth. Mueller C; Baudler S; Welzel H; Böhm M; Nickenig G Circulation; 2002 May; 105(20):2423-8. PubMed ID: 12021231 [TBL] [Abstract][Full Text] [Related]
7. Angiotensin II induces p27(Kip1) expression in renal tubules in vivo: role of reactive oxygen species. Wolf G; Wenzel U; Hannken T; Stahl RA J Mol Med (Berl); 2001 Jul; 79(7):382-9. PubMed ID: 11466560 [TBL] [Abstract][Full Text] [Related]
8. Differential effects of the cyclin-dependent kinase inhibitors p27(Kip1), p21(Cip1), and p16(Ink4) on vascular smooth muscle cell proliferation. Tanner FC; Boehm M; Akyürek LM; San H; Yang ZY; Tashiro J; Nabel GJ; Nabel EG Circulation; 2000 May; 101(17):2022-5. PubMed ID: 10790340 [TBL] [Abstract][Full Text] [Related]
9. p27(Kip1) is important in modulating pulmonary artery smooth muscle cell proliferation. Fouty BW; Grimison B; Fagan KA; Le Cras TD; Harral JW; Hoedt-Miller M; Sclafani RA; Rodman DM Am J Respir Cell Mol Biol; 2001 Nov; 25(5):652-8. PubMed ID: 11713109 [TBL] [Abstract][Full Text] [Related]
10. Reactive oxygen species stimulate p44/42 mitogen-activated protein kinase and induce p27(Kip1): role in angiotensin II-mediated hypertrophy of proximal tubular cells. Hannken T; Schroeder R; Zahner G; Stahl RAK; Wolf G J Am Soc Nephrol; 2000 Aug; 11(8):1387-1397. PubMed ID: 10906152 [TBL] [Abstract][Full Text] [Related]
12. Oxidized LDL induces proliferation and hypertrophy in human umbilical vein endothelial cells via regulation of p27Kip1 expression: role of RhoA. Seibold S; Schürle D; Heinloth A; Wolf G; Wagner M; Galle J J Am Soc Nephrol; 2004 Dec; 15(12):3026-34. PubMed ID: 15579505 [TBL] [Abstract][Full Text] [Related]
13. Differential regulation of p27kip1 levels and CDK activities by hypertrophic and hyperplastic agents in vascular smooth muscle cells. Rao GN Biochim Biophys Acta; 1999 Jan; 1448(3):525-32. PubMed ID: 9990305 [TBL] [Abstract][Full Text] [Related]
14. [Expression of cyclin dependent kinase inhibitor p27 during proliferation in vascular smooth muscle cell]. Yuan Y; Xu DL; Liu YL; Jia MY Sheng Li Xue Bao; 1999 Jun; 51(3):285-90. PubMed ID: 11498990 [TBL] [Abstract][Full Text] [Related]
15. p27kip1 Antisense-induced proliferative activity of rat corneal endothelial cells. Kikuchi M; Harris DL; Obara Y; Senoo T; Joyce NC Invest Ophthalmol Vis Sci; 2004 Jun; 45(6):1763-70. PubMed ID: 15161838 [TBL] [Abstract][Full Text] [Related]
16. Downregulation of cyclin-dependent kinase 2 activity and cyclin A promoter activity in vascular smooth muscle cells by p27(KIP1), an inhibitor of neointima formation in the rat carotid artery. Chen D; Krasinski K; Sylvester A; Chen J; Nisen PD; Andrés V J Clin Invest; 1997 May; 99(10):2334-41. PubMed ID: 9153274 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of vascular smooth muscle cell proliferation by sodium salicylate mediated by upregulation of p21(Waf1) and p27(Kip1). Marra DE; Simoncini T; Liao JK Circulation; 2000 Oct; 102(17):2124-30. PubMed ID: 11044431 [TBL] [Abstract][Full Text] [Related]
18. Angiotensin II-stimulated hypertrophy of LLC-PK1 cells depends on the induction of the cyclin-dependent kinase inhibitor p27Kip1. Wolf G; Stahl RA Kidney Int; 1996 Dec; 50(6):2112-9. PubMed ID: 8943498 [TBL] [Abstract][Full Text] [Related]
19. A receptor-specific function for Notch2 in mediating vascular smooth muscle cell growth arrest through cyclin-dependent kinase inhibitor 1B. Boucher JM; Harrington A; Rostama B; Lindner V; Liaw L Circ Res; 2013 Sep; 113(8):975-85. PubMed ID: 23965337 [TBL] [Abstract][Full Text] [Related]
20. Parathyroid hormone-related protein induces G1 phase growth arrest of vascular smooth muscle cells. Stuart WD; Maeda S; Khera P; Fagin JA; Clemens TL Am J Physiol Endocrinol Metab; 2000 Jul; 279(1):E60-7. PubMed ID: 10893323 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]